0001250853-21-000086.txt : 20210830 0001250853-21-000086.hdr.sgml : 20210830 20210830152017 ACCESSION NUMBER: 0001250853-21-000086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210827 FILED AS OF DATE: 20210830 DATE AS OF CHANGE: 20210830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MONTGOMERY HERBERT D CENTRAL INDEX KEY: 0001022265 STANDARD INDUSTRIAL CLASSIFICATION: HEAVY CONSTRUCTION OTHER THAN BUILDING CONST - CONTRACTORS [1600] STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36225 FILM NUMBER: 211223272 MAIL ADDRESS: STREET 1: C/O ATKINSON STREET 2: 1001 BAYHILL DRIVE 2ND FL CITY: SAN BRUNO STATE: CA ZIP: 94066 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kindred Biosciences, Inc. CENTRAL INDEX KEY: 0001561743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461160142 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-701-7901 MAIL ADDRESS: STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2021-08-27 1 0001561743 Kindred Biosciences, Inc. KIN 0001022265 MONTGOMERY HERBERT D C/O KINDRED BIOSCIENCES, INC. 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 1 0 0 0 Stock Option (right to buy) 3.52 2021-08-27 4 D 0 27500 5.73 D 2026-04-15 Common Stock 27500 0 D Stock Option (right to buy) 4.14 2021-08-27 4 D 0 3350 5.11 D 2026-05-26 Common Stock 3350 0 D Stock Option (right to buy) 6.4 2021-08-27 4 D 0 49900 2.85 D 2027-01-23 Common Stock 49900 0 D Stock Option (right to buy) 8.75 2021-08-27 4 D 0 75000 0.5 D 2028-01-22 Common Stock 75000 0 D Stock Option (right to buy) 9.91 2021-08-27 4 D 0 51500 0 D 2029-01-31 Common Stock 51500 0 D Stock Option (right to buy) 9.84 2021-08-27 4 D 0 51500 0 D 2030-01-16 Common Stock 51500 0 D Stock Option (right to buy) 4.44 2021-08-27 4 D 0 51500 4.81 D 2031-01-19 Common Stock 51500 0 D This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement") in exchange for a cash payment of $157,575.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $17,118.50, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $142,215.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $37,500.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration. This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration. This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $247,715.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. /s/ Herbert Montgomery 2021-08-27